Aerobiotix Raises $25M Growth Equity Financing Led by Global Healthcare Investment Firm Vivo Capital
Founded in 2013, Aerobiotix, a rapidly growing global medical company has raised a $25 million of growth equity financing. The round was led by Vivo Capital with participation by Asahi Kasei Ventures. The new funding will be used to accelerate sales, marketing, and new product development. Aerobiotix products provide mechanical and ultraviolet filtration to remove airborne threats with high efficiency to protect healthcare staff and visitors, and to reduce surgery-related infection risk for patients. The Company’s infection control products have been used to support thousands of procedures across multiple surgical specialty disciplines and in over 175 hospitals and multiple…
More from ProductMore posts in Product »
- PureAir Room 500 X from Vent-Axia Has Seven Stage Purification Process Including UV Sterililzation
- Toyoda Gosei Develops Compact UV-C LED Water Purification Device Applicable in Tight Spaces
- Dyson Humidifier with Ultraviolet Disinfection Makes 2023 Best of List
- Solar Windows from Ubiquitous Energy Convert Ultraviolet and Infrared Waves into Energy
- Orbitrap a Scaled-Down Drug Discovery Device Using Pulsing Ultraviolet Laser to Scan for Alien Life